Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Doctolib
HQ France · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Nov 2025: France's competition authority fined Doctolib about EUR 4.67m for abusing a dominant position via exclusivity clauses, tied subscriptions and its 2018 MonDocteur acquisition; Doctolib denies being dominant and said it will appeal.
Cyber & information governance
Jan 2026: patient data linked to two French providers appeared on a hacking forum; Doctolib said the leak did not come from its servers but from data the providers exported when leaving. Jul 2026: rights group LDH criticised its opt-out use of health data for AI research. NHS DSPT status not yet checked.
Regulatory & clinical safety
Booking, patient engagement and teleconsultation software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract performance
No notable go-lives, troubled implementations, terminations or customer disputes involving Doctolib found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.